New York Life Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,016	Closed	-$238K	–	1324
2022 Q4	$238K	Buy	7,016 +791	+13%	+$26.8K	﹤0.01%	1161
2022 Q3	$299K	Buy	6,225 +457	+8%	+$22K	﹤0.01%	1108
2022 Q2	$329K	Buy	+5,768	New	+$329K	﹤0.01%	1122